DALLAS, Jan. 13, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Peregrine Pharmaceuticals Inc. (Nasdaq:PPHM). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.
The full report is available at: http://www.stockpreacher.com/n/PPHM
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/StockPreacher
Peregrine Pharmaceuticals Inc. (PPHM) is a clinical stage biopharmaceutical company engaged in the development and manufacture of monoclonal antibodies for the treatment of cancer and viral infections. The Company's most advanced platform technologies include phosphatidylserine (PS)-targeting therapy for cancers and for viral diseases and tumor necrosis therapy (TNT). It is pursuing three separate clinical programs in cancer and hepatitis C virus (HCV) infection with its lead product candidates bavituximab and Cotara(R). PPHM also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices Inc. (www.avidbio.com), which provides development and bio-manufacturing services for both the Company and outside customers.
Message Board Search for PPHM: http://www.boardcentral.com/boards/PPHM
In the report, the analyst notes:
"PPHM recently appointed Marvin R. Garovoy MD, as a head of clinical science. Dr. Garovoy brings an intensive experience in the design and conduct of clinical trials for innovative new drugs. According to King, Dr.Garovoy will have primary responsibility for establishing and supervising an Investigator-Sponsored Trials (IST) program, as well as expanding scientific outreach and assisting with clinical trial design for the bavituximab and Cotara(R) programs.
"With significant achievements throughout its business -- the recent positive interactions with the FDA on its next set of bavituximab and cancer trails, the growing importance, sophistication and value of its Avid manufacturing group, the expansion of its senior team to include highly experienced and accomplished industry leaders, the strengthening of its capital structure and its continuing ability to optimistically reinforce its cash position, PPHM looks forward to further advancements in the new year."
To read the entire report visit: http://www.stockpreacher.com/n/PPHM
See what investors say about PPHM at penny stock forum
StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com
StockPreacher.com Disclosure
StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly-owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.